Hubbry Logo
ANA-12ANA-12Main
Open search
ANA-12
Community hub
ANA-12
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
ANA-12
from Wikipedia
ANA-12
Clinical data
ATC code
  • None
Identifiers
  • N-[2-[(2-oxoazepan-3-yl)carbamoyl]phenyl]-1-benzothiophene-2-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.229.925 Edit this at Wikidata
Chemical and physical data
FormulaC22H21N3O3S
Molar mass407.49 g·mol−1
3D model (JSmol)
  • C1CCNC(=O)C(C1)NC(=O)C2=CC=CC=C2NC(=O)C3=CC4=CC=CC=C4S3
  • InChI=1S/C22H21N3O3S/c26-20(25-17-10-5-6-12-23-21(17)27)15-8-2-3-9-16(15)24-22(28)19-13-14-7-1-4-11-18(14)29-19/h1-4,7-9,11,13,17H,5-6,10,12H2,(H,23,27)(H,24,28)(H,25,26)
  • Key:TUSCYCAIGRVBMD-UHFFFAOYSA-N

ANA-12 is a selective, small-molecule non-competitive antagonist of TrkB, the main receptor of brain-derived neurotrophic factor (BDNF).[1] ANA-12 was originally discovered and developed by Cazorla M. and colleagues at Université Paris and Inserm in 2011.[1] The compound crosses the blood-brain-barrier and exerts central TrkB blockade, producing effects as early as 30 minutes (~400 nM) and as long as 6 hours (~10 nM) following intraperitoneal injection in mice.[1] It blocks the neurotrophic actions of BDNF without compromising neuron survival.[1]

Research

[edit]

ANA-12 has two binding sites on TrkB, a high- and low-affinity site (Kd = 10 nM and 12 μM, respectively).

ANA-12 produces rapid antidepressant- and anxiolytic-like effects in animal models,[1] the former of which have been elucidated to be mediated by blockade of BDNF signaling in the nucleus accumbens.[2][3] It has also been found to alleviate methamphetamine-induced depression-like behavior (including anhedonia), behavioral sensitization, and nucleus accumbens neuroplasticity changes with subchronic (14-day) administration in mice, whereas the TrkB agonist 7,8-dihydroxyflavone was ineffective in doing so.[4]

ANA-12 blocks the cognitive-enhancing effects of environmental enrichment and calorie restriction in rodents, which are mediated by BDNF signaling through TrkB in the hippocampus.[5][6] It also blocks hippocampal neurogenesis induced by physical exercise in rodents, and may block the cognitive-enhancing effects of exercise as well.[7]

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
Add your contribution
Related Hubs
User Avatar
No comments yet.